Aberrant trafficking of a proteolipid protein in a mild Pelizaeus-Merzbacher disease

12Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Pelizaeus-Merzbacher disease (PMD) is a rare X-linked leukodystrophy caused by proteolipid protein 1 (PLP1) gene mutations. Previous studies indicated that proteolipid proteins (PLPs) with disease-associated mutations are misfolded and trapped in the endoplasmic reticulum (ER) during transportation to the cell surface, which eventually leads to oligodendrocyte cell death in PMD. Here we report a PMD patient with a very mild phenotype carrying a novel mutation (485G→T) in exon 4 of the PLP1 gene that causes a Trp162Leu substitution in the protein. We also investigated intracellular trafficking of this mutant PLP in COS-7 cells. Transiently transfected mutant PLPW162L fused to an enhanced green fluorescent protein (EGFP) or a short peptide tag was not carried to the plasma membrane. However, in contrast to previous studies, this mutant PLP was not retained in the ER, indicating an escape of the newly translated protein from the quality control machinery. We also found that the mutant PLP accumulated in the nuclear envelope (NE) in a time-dependent manner. This mutant PLP, with its distribution outside the ER and a very mild phenotype, supports the idea that accumulation of misfolded mutant protein in the ER causes the severe phenotype of PMD. © 2006 IBRO.

Cite

CITATION STYLE

APA

Koizume, S., Takizawa, S., Fujita, K., Aida, N., Yamashita, S., Miyagi, Y., & Osaka, H. (2006). Aberrant trafficking of a proteolipid protein in a mild Pelizaeus-Merzbacher disease. Neuroscience, 141(4), 1861–1869. https://doi.org/10.1016/j.neuroscience.2006.05.067

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free